Busulfan, melphalan, and thiotepa with or without total marrow irradiation with hematopoietic stem cell rescue for poor-risk Ewing-Sarcoma-Family tumors.
暂无分享,去创建一个
D. Hawkins | T. Gooley | J. Sanders | W. Bensinger | T. Barnett | Ted A Gooley | W. I. Bensinger | Douglas S. Hawkins | Todd Barnett | Jean E. Sanders
[1] R. Souhami,et al. High-dose busulphan/melphalan with autologous stem cell rescue in Ewing’s sarcoma , 1997, Bone Marrow Transplantation.
[2] H. Grier. The Ewing family of tumors. Ewing's sarcoma and primitive neuroectodermal tumors. , 1997, Pediatric clinics of North America.
[3] D. Linch,et al. Progenitor-cell mobilization after low-dose cyclophosphamide and granulocyte colony-stimulating factor: an analysis of progenitor-cell quantity and quality and factors predicting for these parameters in 101 pretreated patients with malignant lymphoma. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] T. Philip,et al. Autologous stem cell transplantation for solid tumors in children , 1997, Current opinion in pediatrics.
[5] N. Schachar,et al. High-dose melphalan +/- total body irradiation and autologous hematopoietic stem cell rescue for adult patients with Ewing's sarcoma or peripheral neuroectodermal tumor. , 1996, Bone marrow transplantation.
[6] R. Storb,et al. Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant disease. , 1996, Bone marrow transplantation.
[7] R. Storb,et al. High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] R. Storb,et al. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] S. Burdach,et al. Impact of megatherapy in children with high-risk Ewing's tumours in complete remission: a report from the EBMT Solid Tumour Registry. , 1995, Bone marrow transplantation.
[10] F. Appelbaum,et al. Phase I study of high-dose busulfan, melphalan and thiotepa with autologous stem cell support in patients with refractory malignancies. , 1994, Bone marrow transplantation.
[11] S. Steinberg,et al. Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] S. Burdach,et al. Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] F. Appelbaum,et al. Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor , 1993 .
[14] J. Radich,et al. Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] A. Mäkipernaa,et al. High-dose thiotepa with autologous bone marrow rescue in pediatric solid tumors. , 1991, Bone marrow transplantation.
[16] E. Gehan,et al. Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] E. Gehan,et al. Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone: intergroup study IESS-II. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] E. Gehan,et al. Ewing's sarcoma metastatic at diagnosis results and comparisons of two intergroup Ewing's sarcoma studies , 1990, Cancer.
[19] W. Meyer,et al. Therapy for localized Ewing's sarcoma of bone. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] F. Appelbaum,et al. Regimen-related toxicity in patients undergoing bone marrow transplantation. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] W. Enneking,et al. High-risk Ewing's sarcoma: end-intensification using autologous bone marrow transplantation. , 1988, International journal of radiation oncology, biology, physics.
[22] J. Michaelis,et al. Prognostic factors in the treatment of Ewing's sarcoma. The Ewing's Sarcoma Study Group of the German Society of Paediatric Oncology CESS 81. , 1987, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[23] T. Triche,et al. Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] T. Triche,et al. In vitro radiation studies on Ewing's sarcoma cell lines and human bone marrow: application to the clinical use of total body irradiation (TBI). , 1984, International journal of radiation oncology, biology, physics.
[25] R. Marchesini,et al. Sequential half-body irradiation as systemic treatment of progressive Ewing sarcoma. , 1982, International journal of radiation oncology, biology, physics.
[26] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[27] F. Appelbaum,et al. Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factors. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] O. Hartmann. New strategies for the application of high-dose chemotherapy with haematopoietic support in paediatric solid tumours. , 1995, Annals of oncology : official journal of the European Society for Medical Oncology.
[29] R. Storb,et al. Phase II study of busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for allogeneic bone marrow transplantation in patients with advanced myeloid malignancies. , 1995, Bone marrow transplantation.
[30] C. R. Pinkerton,et al. The role of megatherapy with autologous bone marrow rescue in solid tumours of childhood. , 1993, Annals of oncology : official journal of the European Society for Medical Oncology.
[31] W. Winkelmann,et al. Multidisciplinary treatment of primary Ewing's sarcoma of bone. A 6‐year experience of a European cooperative trial , 1988, Cancer.
[32] J. Graham-Pole,et al. High-dose melphalan therapy for the treatment of children with refractory neuroblastoma and Ewing's sarcoma. , 1984, The American journal of pediatric hematology/oncology.